Lymphomas
An Open-label, Multicenter Phase 1b/2 Study to Evaluate the Safety and Efficacy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Details
ClinicalTrials.gov ID:
NCT07520006
Diagnosis Type:
NA
USOR Number:
- Address
,
P: